Pre-referral rectal artesunate in severe malaria: Flawed trial

Trials

Volumn 12, Issue , 2011, Pages

  Hirji, Karim F ^a   Premji, Zulfiqarali G ^a  

^a MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

Author keywords

[No Author keywords available]

Indexed keywords

ARTESUNATE; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE;

ARTICLE; DATA ANALYSIS; DEATH; DISEASE COURSE; DISEASE SEVERITY; EVALUATION; HUMAN; MALARIA; RANDOMIZED CONTROLLED TRIAL (TOPIC); RURAL AREA; SUPPOSITORY; AFRICA; BANGLADESH; CHECKLIST; DOUBLE BLIND PROCEDURE; DRUG ADMINISTRATION; EPIDEMIOLOGY; EVIDENCE BASED MEDICINE; HOSPITALIZATION; INTENTION TO TREAT ANALYSIS; METHODOLOGY; MULTICENTER STUDY (TOPIC); PATIENT REFERRAL; PATIENT SELECTION; PRACTICE GUIDELINE; RECTAL DRUG ADMINISTRATION; REPRODUCIBILITY; SAMPLE SIZE; TIME; TREATMENT OUTCOME; WORLD HEALTH ORGANIZATION;

ADMINISTRATION, RECTAL; AFRICA; ANTIMALARIALS; ARTEMISININS; BANGLADESH; BIAS (EPIDEMIOLOGY); CHECKLIST; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; EVIDENCE-BASED MEDICINE; HUMANS; INTENTION TO TREAT ANALYSIS; MALARIA; MULTICENTER STUDIES AS TOPIC; PATIENT SELECTION; PRACTICE GUIDELINES AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REFERRAL AND CONSULTATION; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN; SAMPLE SIZE; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME; WORLD HEALTH ORGANIZATION;

EID: 79961104138     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-12-188     Document Type: Article

References (82)

1. Gomes MF, Faiz MA, Gyapong JO, Warsame M, Agbenyega T, Babiker A, Baiden F, Yunus EB, Binka F, Clerk C, Folb P, Hassan R, Hossain MA, Kimbute O, Kitua A, Krishna S, Makasi C, Mensah N, Mrango Z, Olliaro P, Peto R, Peto TJ, Rahman MR, Ribeiro I, Samad R, White NJ, . the Study 13 Research Group Pre-referral rectal artesunate to prevent death and disability in severe malaria: A placebo-controlled trial. Lancet 2009, 373:557-566. 10.1016/S0140-6736(08)61734-1, 2646124, 19059639, the Study 13 Research Group.
2. von Seidlein L, Deen JL. Comment: Pre-referral rectal artesunate in severe malaria. Lancet 2009, 373:522-523. 10.1016/S0140-6736(08)61735-3, 19059638.
3. Rectal artesunate and severe malaria: Frequently asked questions on new research findings published in The Lancet . (removed from website -- available from authors) (accessedNovember23,2009)., http://apps.who.int/tdr/news-events/news/pdf/FAQ-Lancet-Study.pdf
4. Background briefing: Treating malaria with rectal artesunate in rural areas saves lives. (removed from website -- available from authors) (accessedNovember23,2009)., http://apps.who.int/tdr/news-events/news/pdf/briefing-Lancet-Study.pdf
5. Hawkes N. BMJ Group Awards honour courage, vision, determination, and insight in medicine. BMJ 2010, 340:617-619.
6. Whitty CJM, Leslie T, Chandler CIR, Staedke SG. Management of severe infections in rural Africa and Asia. BMJ 2010, 340:c1527. 10.1136/bmj.c1527, 20237003.
7. WHO World Malaria Report 2008. Geneva 2008, [ISBN 978 92 4 156369 7], WHO.
8. WHO World Malaria Report 2009. Geneva 2009, [ISBN 978 92 4 156390 1], WHO.
9. Crawley J, Cho C, Mtove G, Nosten F. Seminar: Malaria in children. Lancet 2010, 375:1468-1481. 10.1016/S0140-6736(10)60447-3, 20417858.
10. Tazan Y, Klein EY, Darley S, Panicker R, Laxminarayan R, Breman JG. Pre-referral artesunate for treatment of severe childhood malaria: A cost-effectiveness analysis. Lancet 2010, 376:1910-1915. 10.1016/S0140-6736(10)61460-2, 21122910.
11. Bello SO. Pre-referral rectal artesunate in severe malaria (letter). Lancet 2009, 373:1762-1763. 10.1016/S0140-6736(09)60980-6, 19465228.
12. Jadad AR, Enkin MW. Randomized Controlled Trials: Questions, Answers and Musings 2007, Oxford, UK: Blackwell Publishing/BMJ Books, 2.
13. Moher D, Schulz KF, Altman DG. The CONSORT statement: Revised recommendations for improving the quality of reports of parallel group randomized trials. Annals of Internal Medicine 2001, 134:657-662.
14. Altman DG, Schulz KF, Moher D, Egger M, Davidoff F, Elbourne D, Gøtzsche PC, Lang T. The revised CONSORT statement for reporting randomized trials: Explanations and elaboration. Annals of Internal Medicine 2001, 134:6663-6694.
15. Persaud N, Mamdani MM. External validity: The neglected dimension in evidence ranking. Journal of Evaluation in Clinical Practice 2006, 12:450-45?. 10.1111/j.1365-2753.2006.00730.x, 16907689.
16. Rothwell PM. External validity of randomised controlled trials: "To whom do the results of this trial apply?". Lancet 2005, 365:82-93. 10.1016/S0140-6736(04)17670-8, 15639683.
17. Weiss NS, Koepsell TD, Psaty BM. Generalizability of the results of randomized trials. Archives of Internal Medicine 2008, 168:133-135. 10.1001/archinternmed.2007.30, 18227357.
18. Abramson JH. WINPEPI (PEPI-for-Windows): Computer programs for epidemiologists. Epidemiologic Perspectives & Innovations 2004, 1:6. 10.1186/1742-5573-1-6, 21824168.
19. Kitua A, Folb P, Warsame M, Binka F, Faiz A, Ribeiro I, Peto T, Gyapong J, Yunus EB, Rahman R, Baiden F, Clerk C, Mrango Z, Makasi C, Kimbute O, Hossain A, Samad R, Gomes M. The use of placebo in a trial of rectal artesunate as initial treatment for severe malaria patients en route to referral clinics: Ethical issues. Journal of Medical Ethics 2010, 36:116-120. 10.1136/jme.2009.030874, 20133408.
20. Gomes MF, Warsame M, Nasemba N, Singlovic J, Kapinga A, Mwankuyse S, Mduma S, Msabaha MH, Mulokosi F, Shishira J, Kitua A, Mrango Z. Gaining time: Early treatment of severe pediatric malaria in Tanzania. Drug Development Research 2010, 71:92-98. [Erratum: 71:219-220.].
21. Chan AW, Hrøbjartsson A, J JK, Gøotzsche PC, Altman DG. Discrepancies in sample size calculations and data analyses reported in randomised trials: Ccomparison of publication with protocols. BMJ 2008, 337:a2299. 10.1136/bmj.a2299, 2600604, 19056791.
22. Thera MA, Keita F, Sissoko MS, Traore OB, Coulibaly D, Sacko M, Lamyere V, Ducret JP, Doumbo O. Acceptability and efficacy of intra-rectal quinine alkaloids as a pre-transfer treatment of non per os malaria in peripheral health care facilities in Mopti, Mali. Malaria Journal 2007, 6:68. 10.1186/1475-2875-6-68, 1904225, 17519031.
23. Ajayi IO, Browne EN, Bateganya F, Yar D, Happi C, Falade CO, Gbotosho GO, Yusuf B, Boateng S, Mugittu K, Cousens S, Nanyunja M, Pagoni F. Effectiveness of artemisinin-based combination therapy used in the context of home management of malaria: A report from three study sites in sub-Sharan Africa. Malaria Journal 2008, 7:190. 10.1186/1475-2875-7-190, 2567328, 18822170.
24. WHO Malaria: A Manual for Community Health Workers Geneva 1996, [ISBN 92 4 154491 0], WHO.
25. Bhattacharyya K, Winch P, LeBan K, Tien M. Community Health Worker Incentives and Disincentives: How They Affect Motivation, Retention and Sustainablity 2001, Arlington, Virginia: USAID - BASICS II, [Basic Support for Institutionalizing Child Survival Project - II].
26. Maitland K. Severe malaria: Lessons learned from the management of critical illness in children. Trends in Parasitology 2006, 22:457-462. 10.1016/j.pt.2006.07.006, 16890024.
27. Akech SO, Hassall O, Pamba A, Idro R, Williams TN, Newton CRJC, Maitland K. Survival and haematological recovery of children with severe malaria transfused in accordance with WHO guidelines in Kilifi, Kenya. Malaria Journal 2008, 7:256. 10.1186/1475-2875-7-256, 2615447, 19087286.
28. Phiri KS, Calis JCJ, Faragher B, Nkhoma K, Mangochi B, Molyneux ME, van Hensbroek MB. Long term outcome of severe anaemia in Malawian children. PLoS One 2008, 3:e2903. 10.1371/journal.pone.0002903, 2488370, 18682797.
29. Ekvall H, Premji Z, Bjorkman A. Chloroquine treatment for uncomplicated childhood malaria aggravates anaemia in a drug resistant area of Tanzania. Transactions of the Royal Society of Tropical Medicine and Hygiene 1998, 92:556-560. 10.1016/S0035-9203(98)90913-0, 9861379.
30. Delley V, Bouvier P, Breslow N, Doumbo O, Sagara I, Diakite M, Mauria A, Dolo A, Rougemont A. What does a single determination of malaria parasite density mean? A longitudinal survey in Mali. Tropical Medicine and International Health 2000, 5:404-412. 10.1046/j.1365-3156.2000.00566.x, 10929139.
31. Yeboah-Antwi K, Pillingana P, Macleod WB, Semrau K, Siazeele K, Kalesha P, Hamainza B, Seidenberg P, Mazimba A, Sabin L, Kamholz K, Thea DM, Hamer DH. Community case management of fever due to malaria and pneumonia in children under five in Zambia: A cluster randomized controlled trial. PLoS Medicine 2010, 7:e1000340. 10.1371/journal.pmed.1000340, 2943441, 20877714.
32. Sazawal S, Black RE. Effect of pneumonia case management on mortality in neonates, infants and preschool children: A meta-analysis of community-based trials. Lancet Infectious Diseases 2003, 3:547-556. 10.1016/S1473-3099(03)00737-0, 12954560.
33. Premji Z, Minjas JN, Shiff CJ. Laboratory diagnosis of malaria by village health wrokers using the rapid manual ParaSight™-F test. Transactions of the Royal Society of Tropical Medicine and Hygiene 1994, 88:418. 10.1016/0035-9203(94)90409-X, 7570824.
34. Blyth C. Simpson's paradox and the sure-thing principle. Journal of the American Statistical Association 1972, 67:364-366.
35. Rabbani GH, Larson CP, Islam R, Saha UR, Kabir A. Green banana-supplemented diet in the home management of acute and prolonged diarrhoea in children: A community-based trial in rural Bangladesh. Tropical Medicine and International Health 2010, 15:1132-1139. 10.1111/j.1365-3156.2010.02608.x, 20831671.
36. Nuesch E, Trelle S, Reichenbach S, Rutjes AWS, Burgi E, Scherer M, Altman DG, Juni P. The effects of excluding patients from the analysis in randomised controlled trials: Meta-epidemiologic study. BMJ 2009, 339:b3244. 10.1136/bmj.b3244, 2739282, 19736281.
37. Altman DG. Missing outcomes in randomized trials: Addressing the dilemma. Open Medicine 2009, 3(2):e21-e23., http://www.openmedicine.ca
38. Montori VM, Guyatt GH. Intention-to-treat principle. Canadian Medical Association Journal 2001, 165:1339-1341. 81628, 11760981.
39. Schulz KF, Grimes DA. Multiplicity in randomized trials I: Endpoints and treatments. Lancet 2005, 365:1591-1595. 10.1016/S0140-6736(05)66461-6, 15866314.
40. DerSimonina R, Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials 1987, 7:177-188.
41. Bellemare S, Hartling L, Wiebe N, et al. Oral rehydration versus intravenous therapy for treating dehydration due to gastroenteritis in children: A meta-analysis of controlled trials. BMC Medicine 2004, 2:11. 10.1186/1741-7015-2-11, 419333, 15086953., http://www.biomedcentral.com/1741-7015/2/11
42. Assmann SF, Pocock SJ, Enos LE, Kasten LE. Subgroup analysis and other (mis)uses of baseline data in clinical trials. Lancet 2000, 355:1064-1069. [comments in: Lancet, 355:1033-1034], 10.1016/S0140-6736(00)02039-0, 10744093.
43. Cook DI, Gebski VJ, Keech AC. Subgroup analysis in clinical trials. Medical Journal of Australia 2004, 180:289-291.
44. Fletcher J. Subgroup analyses: How to avoid being misled. BMJ 2007, 335:96-97. 10.1136/bmj.39265.596262.AD, 1914513, 17626964.
45. Lagakos SW. The challenge of subgroup analyses - reporting without distorting. NEJM 2006, 354:1667-1669. [comments in: NEJM, 355:211-212], 10.1056/NEJMp068070, 16625007.
46. Oxman AD, Guyatt GH. A consumer's guide to subgroup analyses. Annals of Internal Medicine 1992, 116:78-84.
47. Pocock SJ, Assmann SE, Enos LE, Kasten LE. Subgroup analysis, covariate adjustment and baseline comparisons in clinical trial reporting: Current practice and problems. Statistics in Medicine 2002, 21:2917-2930. 10.1002/sim.1296, 12325108.
48. Rothwell PM. Treating Individuals 2. Subgroup analysis in randomized controlled trials: Importance, indications, and interpretation. Lancet 2005, 365:176-186. 10.1016/S0140-6736(05)17709-5, 15639301.
49. Schulz KF, Grimes DA. Multiplicity in randomized trials II: Subgroup and interim analyses. Lancet 2005, 365:1657-1661. 10.1016/S0140-6736(05)66516-6, 15885299.
50. Wang R, Lagakos SW, Ware JH, Hunter DJ, Drazen JM. Statistics in Medicine--Reporting of subgroup analyses in clinical trials. NEJM 2007, 357:2189-2194. 10.1056/NEJMsr077003, 18032770.
51. Yusuf S, Wittes J, Probstfield J, Tyroler HA. Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials. JAMA 1991, 266:93-98. 10.1001/jama.266.1.93, 2046134.
52. Morrison DA. How to improve statistical analysis in parasitology research publications? (letter). International Journal for Parasitology 2002, 32:1065-1070. 10.1016/S0020-7519(02)00064-4, 12076635.
53. Schatz P, Jay KA, McComb JR, McLaughlin JR. Misuse of statistical tests in Archives of Clinical Neurology publications. Archives of Clinical Neuropsychology 2005, 20:1053-1059. 10.1016/j.acn.2005.06.006, 16095871.
54. Hennekens CH, DeMets D. The need for large-scale randomized evidence without undue emphasis on small trials, meta-analyses, or subgroup analyses. JAMA 2009, 302:2361-2362. 10.1001/jama.2009.1756, 19952322.
55. Guillemin F. Primer: The fallacy of subgroup analysis. Rheumatology Clinical Practice 2007, 3:407-413.
56. Sun X, Briel M, Walter SD, Guyatt GH. Is subgroup analysis believable? Updating criteria to evaluate the credibility of subgroup analyses. British Medical Journal 2010, 340:850-854.
57. Hirji KF, Fagerland MW. Outcome based subgroup analysis: A negelected concern. Trials 2009, 10:9. 10.1186/1745-6215-10-9, 2654883, 19200379., http://www.trialsjournal.com/content/10/1/33
58. van Walraven C, Davis D, Forster AJ, Wells GA. Time-dependent bias was common in survival analyses published in leading clinical journals. Journal of Clinical Epidemiology 2004, 57:672-682. 10.1016/j.jclinepi.2003.12.008, 15358395.
59. Brett AS. Treating hypercholesterolemia: How should practicing physicians interprete published data for patients. NEJM 1989, 321:676-680. 10.1056/NEJM198909073211009, 2519528.
60. Sinclair JC, Bracken MB. Clinically useful measures of effect in binary analyses of randomized trials. Journal of Clinical Epidemiology 1994, 47:881-889. 10.1016/0895-4356(94)90191-0, 7730891.
61. Lengeler C, Armstrong-Schellenberg J, D'Allesandro U, Binka F, Cattani J. Relative versus absolute risk of dying reduction after using insecticide-treated nets for malaria control in Africa. Tropical Medicine and International Health 1998, 3:286-290. 10.1046/j.1365-3156.1998.00236.x, 9623929.
62. Lengeler C, Snow RW. From efficacy to effectiveness: Insecticide-treated nets in Africa. Bulletin of the World Health Organization 1996, 74:325-332. 2486924, 8789931.
63. Simba DO, Warsame M, Kimbute O, Kakoko D, Petzold M, Tomson G, Premji Z, Gomes M. Factors influencing adherence to referral advice following pre-referral treatment with artesunate suppositories in children in rural Tanzania. Tropical Medicine and International Health 2009, 14:775-783. 10.1111/j.1365-3156.2009.02299.x, 19497077.
64. Gomes MF, Makubalo L, Gyapong J, Faiz A, Warsame M, . the Study 13 Research Group Authors' reply: Pre-referral artesunate in severe malaria (letter). Lancet 2009, 373:1763. the Study 13 Research Group.
65. West S, Munoz B, Lynch M, Rayongoya A, Chilangwa Z, Mmbaga BBO, Taylor HR. Impact of face-washing on trachoma in Kongwa, Tanzania. Lancet 1995, 345:155-159. 10.1016/S0140-6736(95)90167-1, 7823670.
66. Glickman SW, McHutchison JG, Peterson ED, Cairns CB, Harrington RA, Califf RM, Schulman KA. Ethical and scientific implications of the globalization of clinical research. NEJM 2009, 360:816-823. 10.1056/NEJMsb0803929, 19228627.
67. Hrobjartsson A, Jorgensen K, Hilden J, Altman DG, Gøtzsche PC. Impact of allocation concealment on conclusions drawn from meta-analyses of randomized trials. International Journal of Epidemiology 2007, 36:847-857. 10.1093/ije/dym087, 17517809.
68. Faulkner C, Fidler F, Cumming G. The value of RCT evidence depends on the quality of statistical analysis. Behaviour Research and Therapy 2008, 46:270-281. 10.1016/j.brat.2007.12.001, 18191102.
69. Bath FJ, Owen VE, Bath PM. Quality of full and final publications reporting acute stroke trials: A systematic review. Stroke 1998, 10:2203-2210.
70. Hotopf M, Lewis G, Normand C. Putting trials on trial - the costs and consequences of small trials in depression: A systematic review of methodology. Journal of Epidemiology and Community Health 1997, 51:354-358. 10.1136/jech.51.4.354, 1060500, 9328538.
71. Altman DG. Poor-quality medical research: What can journals do?. JAMA 2002, 287:2765-2767. 10.1001/jama.287.21.2765, 12038906.
72. Chan AW, Altman DG. Epidemiology and reporting of randomised trials published in PubMed journals. Lancet 2005, 365:1159-1162. 10.1016/S0140-6736(05)71879-1, 15794971.
73. Henderson M. End of the peer review show?. BMJ 2010, 340:739-740.
74. Hirji KF. Assessing the quality of clinical trials: Is there a short-cut?. Trials 2009, 10:1. 10.1186/1745-6215-10-1, 2636799, 19128475., http://www.trialsjournal.com/content/10/1/1
75. Gravel J, Opatrny L, Shapiro S. The intention-to-treat approach in randomized controlled trials: Are authors saying what they do and doing what they say?. Clinical Trials 2007, 4:350-356. 10.1177/1740774507081223, 17848496.
76. Herman A, Botser IB, Tenenbaum S, Chechick A. Intention-to-treat analysis and accounting for missing data in orthopaedic randomized clinical trials. Journal of Bone and Joint Surgery of America 2009, 91:2137-2143.
77. Kruse RL, Alper BS, Reust C, Stevermer JJ, Shannon S, Williams RH. Intention-to-treat analysis: Who is in? Who is out?. Journal of Family Practice 2002, 51:969-971. [Erratum: JFP, 51:1079].
78. Comoro C, Nsimba SED, Warsame M, Tomson G. Local understanding, perceptions and reported practices of mothers/guardians and health workers on childhood malaria in a Tanzania district - Implications for malaria control. Acta Tropica 2003, 87:305-313. 10.1016/S0001-706X(03)00113-X, 12875923.
79. Maslove DM, Mnyusiwalla A, Mills EJ, McGowan J, Attaran A, Wilson K. Barriers to the effective treatment and prevention of malaria in Africa: A systematic review of qualitative studies. BMC International Health and Human Rights 2009, 9:26. 10.1186/1472-698X-9-26, 2782321, 19852857.
80. Kaona FAD, Tuba M. A qualitative study to identify community structures for management of severe malaria: A basis for introducing rectal artesunate in the under five years children in Nakonde District of Zambia. BMC Public Health 2005, 5:28. 10.1186/1471-2458-5-28, 1079879, 15792501.
81. Day N, Dondrop AM. The management of patients with severe malaria. American Journal of Tropical Medicine and Hygiene 2007, 77(Suppl 6):29-35.
82. Chuma J, Okungu V, Molyneux C. Barriers to prompt and effective malaria treatment among the poorest population in Kenya. Malaria Journal 2010, 9:144. 10.1186/1475-2875-9-144, 2892503, 20507555.